GILEAD SCIENCES, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $30.4b $26.1b $22.1b $22.4b $24.7b $27.3b $27.3b $27.1b $28.8b $29.4b
Cost of Revenue $4.3b $4.4b $4.9b $4.7b $4.6b $6.6b $5.7b $6.5b $6.3b $6.2b
Cost of goods sold $4.3b $4.4b $4.9b $4.7b $4.6b $6.6b $5.7b $6.5b $6.3b $6.2b
Gross Profit (Calculated) $26.1b $21.7b $17.3b $17.8b $20.1b $20.7b $21.6b $20.6b $22.5b $23.2b
In-process research and development impairments $0 $0 $2.7b $50.0m $4.2b $590.0m
Operating expenses:
Operating Income (Loss) $17.6b $14.1b $8.2b $4.3b $4.1b $9.9b $7.3b $7.6b $1.7b $10.0b
Additional Financial Items
Amortization of Intangible Assets $1.8b $2.3b $2.4b $2.4b
Fair Value, Option, Changes in Fair Value, Gain (Loss) ($128.0m)
Income (Loss) from Continuing Operations before Income Taxes, Domestic $7.6b $8.1b $7.1b $4.1b $2.5b $8.6b $4.4b $5.5b ($876.0m) $8.3b
Net loss attributable to noncontrolling interest ($13.0m) $16.0m $5.0m ($22.0m) ($34.0m) $24.0m $26.0m $52.0m $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $7.8b $5.2b $1.7b $8.3b $5.8b $6.9b $690.0m $9.8b
Income before income taxes $7.8b $5.2b $1.7b $8.3b $5.8b $6.9b $690.0m $9.8b
Net Income (Loss) Attributable to Parent $13.5b $4.6b $5.5b $5.4b $123.0m $6.2b $4.6b $5.7b $480.0m $8.5b
Net Income (Loss) Attributable to Noncontrolling Interest ($13.0m) $16.0m $5.0m ($22.0m) ($34.0m) ($24.0m) ($26.0m) ($52.0m) $0 $0
Common Stock, Dividends, Per Share, Declared $1.84 $2.08 $2.28 $2.52 $2.72 $2.84 $2.92 $0.75 $3.08 $3.16
Earnings Per Share, Basic $10.08 $3.54 $4.20 $4.24 $0.10 $4.96 $3.66 $4.54 $0.38 $6.84
Earnings Per Share, Diluted $9.94 $3.51 $4.17 $4.22 $0.10 $4.93 $3.64 $4.50 $0.38 $6.78
Weighted Average Number of Shares Outstanding, Basic 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b 1.2b 1.2b 1.2b
Weighted Average Number of Shares Outstanding, Diluted 1.4b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b
Acquired in-process research and development expenses $1.1b $5.1b $5.9b $177.0m $944.0m $1.2b $4.7b $1.0b
Costs and Expenses $12.8b $12.0b $13.9b $18.2b $20.6b $17.4b $20.0b $19.5b $27.1b $19.4b
Income tax (benefit) expense $3.6b $8.9b $2.3b ($204.0m) $1.6b ($2.1b) ($1.2b) ($1.2b) $211.0m $1.3b
Interest Expense $964.0m $1.1b $1.1b $995.0m $984.0m $1.0b $935.0m $944.0m $977.0m $1.0b
Interest Expense (non-operating) $977.0m $1.0b
Operating Lease, Expense $162.0m $171.0m $156.0m $162.0m $165.0m $163.0m $169.0m
Other (income) expense, net $428.0m $523.0m $676.0m $1.9b ($1.4b) ($639.0m) ($581.0m) $198.0m ($6.0m) ($798.0m)
Other Nonoperating Income (Expense) ($2.0m) ($1.0m)
Research and Development Expense $5.1b $3.7b $5.0b $9.1b $5.0b $5.4b $5.0b $5.7b $5.9b $5.8b
Research and development expenses $5.1b $3.7b $5.0b $9.1b $5.0b $5.4b $5.0b $5.7b $5.9b $5.8b
Selling, General and Administrative Expense $3.4b $3.9b $4.1b $4.4b $5.2b $5.2b $5.7b $6.1b $6.1b $5.8b
Selling, general and administrative expenses $3.4b $3.9b $4.1b $4.4b $5.2b $5.2b $5.7b $6.1b $6.1b $5.8b
Income Tax Expense (Benefit) $3.6b $8.9b $2.3b ($204.0m) $1.6b $2.1b $1.2b $1.2b $211.0m $1.3b
Total costs and expenses $12.8b $12.0b $13.9b $18.2b $20.6b $17.4b $20.0b $19.5b $27.1b $19.4b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.